Dergiler / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 11

Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Sayfa
964–975
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

SIBO was associated with vasodilation and hyperdynamic circulation in decompensated cirrhosis (p=0.002; p=0.012),but not in compensated cirrhosis (p=1.000; p=0.474).Conclusions: SIBO is associated with hyperdynamic circulation and other hemodynamic changes in cirrhosis and may be a principalfactor causing these through systemic inflammation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Small intestinal bacterial overgrowth (SIBO) and hemodynamic changes are common in cirrhosis.
📊
Temel Bulgular & Veri:We wanted toexamine our hypothesis whether SIBO leads to hemodynamic changes in cirrhosis.Materials and Methods: A total of 50 patients with cirrhosis and 15 healthy controls were enrolled in a pilot prospective study.
💡
Sonuç & Katkı:SIBO was associated with vasodilation and hyperdynamic circulation in decompensated cirrhosis (p=0.002; p=0.012),but not in compensated cirrhosis (p=1.000; p=0.474).Conclusions: SIBO is associated with hyperdynamic circulation and other hemodynamic changes in cirrhosis and may be a principalfactor causing these through systemic inflammation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Small intestinal bacterial overgrowth (SIBO) and hemodynamic changes are common in cirrhosis. We wanted toexamine our hypothesis whether SIBO leads to hemodynamic changes in cirrhosis.Materials and Methods: A total of 50 patients with cirrhosis and 15 healthy controls were enrolled in a pilot prospective study. All participants underwent the lactulose hydrogen breath test for SIBO and echocardiography with a simultaneous assessment of blood pressureand heart rate. Cardiac output and systemic vascular resistance were calculated.Results: Study participants with SIBO had a lower systolic blood pressure and systemic vascular resistance compared to those without SIBO and to healthy controls (110.2±12.3 mmHg vs. 126.2±21.0 mmHg and 121.2±9.8 mmHg; p=0.005 and p=0.011, respectively; 1312±352 dyn•s•$cm^{-5}$ vs. 1704±424 dyn•s•$cm^{-5}$ and 1648±272 dyn•s•$cm^{-5}$; p=0.001 and p=0.006, respectively), but a higher cardiacoutput (5.38±1.41 l/min vs. 4.52±1.03 l/min and 4.40±0.68 l/min; p=0.034 and p=0.041, respectively) and C-reactive protein (10.5[1.2-16.5] mg/l vs. 2.8[0.6-9.1] mg/l; p=0.028; no comparison with healthy controls). There were no significant differences between patientswithout SIBO and healthy controls with regard to systolic blood pressure (p=0.554), systemic vascular resistance (p=0.874), and cardiacoutput (p=0.795). SIBO was associated with vasodilation and hyperdynamic circulation in decompensated cirrhosis (p=0.002; p=0.012),but not in compensated cirrhosis (p=1.000; p=0.474).Conclusions: SIBO is associated with hyperdynamic circulation and other hemodynamic changes in cirrhosis and may be a principalfactor causing these through systemic inflammation.

🔖

Bu Makaleye Atıf Yap

MASLENNIKOV, R., PAVLOV, C., IVASHKIN, V. (2019). Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 11, 964–975. https://ajindex.com/articles/411299

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest 1953
  2. [CrossRef] 2. Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958
  3. [CrossRef] 3. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006
  4. 43(2 Suppl 1): S121-31. [CrossRef] 4. Koutsounas I, Kaltsa G, Siakavellas SI, et al. Markers of bacterial translocation in end-stage liver disease. World J Hepatol 2015
  5. [CrossRef] 5. Giannelli V, Di gregorio V, Iebba V, et al. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. World J Gastroenterol 2014
  6. 16795-810. [CrossRef] 6. Bernardi M., Moreau R, Angeli P, et al. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol 2015
  7. [CrossRef] 7. Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep 2016
  8. [CrossRef] 8. Koh IH, Guatelli R, Montero EF, et al. Where is the site of bacterial translocation -- small or large bowel? Transplant Proc 1996
  9. Lakshmi CP, Ghoshal UC, Kumar S, et al. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction. Dig Dis Sci 2010
  10. [CrossRef] 10. Shah A, Shanahan E, Macdonald GA, Fletcher L, Ghasemi P, Morrison M, Jones M, Holtmann G. Systematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver Disease. Semin Liver Dis 2017
  11. [CrossRef] 11. Zhang Y, Feng Y, Cao B, Tian Q. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis. Int J Clin Exp Med 2015
  12. Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009
  13. [CrossRef] 13. Zharkova MS, Mayevskaya MV, Ivashkin VT. The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis. RJGHC 2012
  14. [CrossRef] 14. Pugh R, Murraylyon I, Dawson J. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973
  15. [CrossRef] 15. Rezaie A, Buresi M, Lembo A, et al. Hydr